Test - Physician's Channel - Mount Sinai New York

Skip to main content

Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.

Refer a Patient Online

Or call 212-241-4983

Featured Items

New Content

New Technique for Kidney Stone Removal Yields Significant Gains in Safety and Outcomes

New Technique for Kidney Stone Removal Yields Significant Gains in Safety and Outcomes

A Mount Sinai physician has pioneered a novel technique for removing renal stones that dispenses entirely with fluoroscopy, as well as with the ureteral access sheath and post-operative stenting.

New Technologies, Initiatives Offer More Options for Management and Treatment of Benign Prostatic Hyperplasia

New Technologies, Initiatives Offer More Options for Management and Treatment of Benign Prostatic Hyperplasia

Mount Sinai is adopting new approaches to diagnosis and treatment of benign prostatic hyperplasia (BPH) and engaging patients through innovative disease awareness and management applications.

Research Explores Dupilumab as a Weapon Against Lung Cancer

Research Explores Dupilumab as a Weapon Against Lung Cancer

Dupilumab, a monoclonal antibody blocking interleukin-4 receptor-alpha (IL-4RAlpha), is an effective treatment for moderate to severe asthma and multiple allergic conditions. Mount Sinai researcher Thomas Marron, MD, PhD, believes it also ...

Robotic Bronchoscopic Cryobiopsy Improves Diagnostic Yield Without Compromising Safety

Robotic Bronchoscopic Cryobiopsy Improves Diagnostic Yield Without Compromising Safety

Traditional guided bronchoscopy isn't good at reaching certain small lesions and some areas of the lung. As a result, diagnostic yields—the proportion of biopsies that result in a specific diagnosis—tended to hover around 60-70 percent. ...

A Better Way to Detect and Prevent Suicidality Over Time

A Better Way to Detect and Prevent Suicidality Over Time

Relying on suicidal ideation as a way to detect suicide is ineffective, as the majority of people who died by suicide do not report such intent. A Mount Sinai clinician has developed an alternative model that incorporates evidence-based ...

Expanding an Integrated Model for Substance Use and Mental Health Treatment for Youths

Expanding an Integrated Model for Substance Use and Mental Health Treatment for Youths

Youth with untreated mental health and substance use issues have limited, siloed options for getting help. An integrated, multidisciplinary Mount Sinai program enabling New York City high school students to address those challenges is ...

Probing the Hidden Link Between Osteoporosis and Alpha-1 Antitrypsin Deficiency

Probing the Hidden Link Between Osteoporosis and Alpha-1 Antitrypsin Deficiency

With a recent grant from the Alpha-1 Foundation, Mount Sinai’s Nilsson Holguin, PhD, is exploring a link between alpha-1 antitrypsin deficiency, a rare genetic disorder commonly recognized as a disease of the lungs and liver, and osteoporosis, ...

Lymphangioma of the Tibial Nerve: A Rare Cause of Neuropathy

Lymphangioma of the Tibial Nerve: A Rare Cause of Neuropathy

Lymphangiomas are benign congenital malformations of the lymphatic vessels characterized by dilated vascular channels filled with lymphatic fluid. While some may develop after any trauma or damage to these lymphoid tissues or lymph pathways, ...

Scientists Demonstrate the Tremendous Promise of AI and Machine Learning for Predicting Stroke And Other Neurological Disorders

Scientists Demonstrate the Tremendous Promise of AI and Machine Learning for Predicting Stroke And Other Neurological Disorders

Identifying acute stroke remains one of the toughest challenges facing emergency medicine and neurology. Traditional stroke alert systems register false positive results in up to two-thirds of cases, resulting in inefficient utilization ...

Mount Sinai Helps Set a New Standard for Treating Alcohol-Related Liver Disease

Mount Sinai Helps Set a New Standard for Treating Alcohol-Related Liver Disease

Mount Sinai has become a leading site for the treatment of alcohol-related liver disease in the New York metropolitan region, and one of a handful in the country with a comprehensive center for addressing the sizable population of patients ...

Mount Sinai Rolls Out Innovative Program for Comprehensive Care for Older Adults With HIV

Mount Sinai Rolls Out Innovative Program for Comprehensive Care for Older Adults With HIV

The success of Mount Sinai’s Comprehensive Care for Older Adults With HIV Program, which uses a collaborative team approach, including a community health worker, is leading to the rollout of the program to other institutions nationwide.

Specialty Reports November 2025

Specialty Reports November 2025

Science & Medicine The Magazine of the Mount Sinai Health System

Science & Medicine The Magazine of the Mount Sinai Health System

Driving Innovation, Advancing Health, Caring for Patients

Current Heart Attack Screening Tools Are Not Optimal and Fail to Identify Half the People Who Are at Risk

Current Heart Attack Screening Tools Are Not Optimal and Fail to Identify Half the People Who Are at Risk

Mount Sinai study shows that traditional risk scores and symptoms such as chest pain should not be solely relied upon to prevent cardiovascular events

Protective Microglia Subtype Offers Potential New Therapeutic Pathway in Alzheimer’s Disease

Protective Microglia Subtype Offers Potential New Therapeutic Pathway in Alzheimer’s Disease

International research team identifies distinct population of neuroprotective immune cells of the central nervous system

A Specific Human Gene Can Help the Heart Repair Itself From Heart Attack or Heart Failure

A Specific Human Gene Can Help the Heart Repair Itself From Heart Attack or Heart Failure

First-ever discovery by Hina Chaudhry, MD of Mount Sinai could lead to new and less invasive treatments

Mount Sinai Awarded $4.5M BD2 Grant to Advance Research on the Biology of Bipolar Disorder

Mount Sinai Awarded $4.5M BD2 Grant to Advance Research on the Biology of Bipolar Disorder

The Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: Breakthrough Discoveries for thriving with Bipolar Disorder to investigate the neural mechanisms underlying bipolar ...

Specialty Reports October 2025

Specialty Reports October 2025

Mount Sinai Health System is pleased to present these reports covering our groundbreaking research and compassionate, equitable, and safe patient care.